"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 2 | 1 | 3 |
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 1 | 2 |
| 1998 | 3 | 2 | 5 |
| 1999 | 6 | 2 | 8 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 7 | 4 | 11 |
| 2003 | 7 | 1 | 8 |
| 2004 | 8 | 5 | 13 |
| 2005 | 10 | 4 | 14 |
| 2006 | 13 | 7 | 20 |
| 2007 | 7 | 9 | 16 |
| 2008 | 6 | 6 | 12 |
| 2009 | 13 | 5 | 18 |
| 2010 | 10 | 1 | 11 |
| 2011 | 15 | 5 | 20 |
| 2012 | 13 | 4 | 17 |
| 2013 | 15 | 3 | 18 |
| 2014 | 17 | 4 | 21 |
| 2015 | 18 | 7 | 25 |
| 2016 | 31 | 4 | 35 |
| 2017 | 17 | 6 | 23 |
| 2018 | 9 | 1 | 10 |
| 2019 | 18 | 5 | 23 |
| 2020 | 14 | 1 | 15 |
| 2021 | 16 | 2 | 18 |
| 2022 | 22 | 0 | 22 |
| 2023 | 10 | 0 | 10 |
| 2024 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. J Natl Cancer Inst. 2024 Aug 01; 116(8):1384-1394.
-
Cardiovascular Risk Estimation Is Suboptimal in People With HIV. J Am Heart Assoc. 2024 May 21; 13(10):e029228.
-
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis. BMJ Open Diabetes Res Care. 2024 May 06; 12(3).
-
Hypertension, Cardiovascular Risk Factors, and Uterine Fibroid Diagnosis in Midlife. JAMA Netw Open. 2024 Apr 01; 7(4):e246832.
-
Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
-
Childhood maltreatment and trajectories of cardiometabolic health across the reproductive life span among individuals with a first birth during the Coronary Artery Risk Development in Young Adults Study. Prev Med. 2024 Mar; 180:107894.
-
Cardiovascular disease risk management during COVID-19: in-person vs virtual visits. Am J Manag Care. 2024 Jan 01; 30(1):e11-e18.
-
Pre-diagnosis lipid levels and mortality after obesity-related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort. Cancer Med. 2023 08; 12(15):16626-16636.
-
A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer Res Commun. 2023 06; 3(6):1104-1112.
-
Proteomic cardiovascular risk assessment in chronic kidney disease. Eur Heart J. 2023 06 20; 44(23):2095-2110.